Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: October 7, 2022


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which patents cover Indocyanine Green, and what generic alternatives are available?

Indocyanine Green is a drug marketed by Renew Pharms and is included in one NDA.

The generic ingredient in INDOCYANINE GREEN is indocyanine green. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the indocyanine green profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Indocyanine Green

A generic version of INDOCYANINE GREEN was approved as indocyanine green by RENEW PHARMS on November 21st, 2007.

  Try it Free

Drug patent expirations by year for INDOCYANINE GREEN
Recent Clinical Trials for INDOCYANINE GREEN

Identify potential brand extensions & 505(b)(2) entrants

UMC UtrechtPhase 3
Instituto de Investigación Biomédica de SalamancaPhase 4
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y LeónPhase 4

See all INDOCYANINE GREEN clinical trials

Medical Subject Heading (MeSH) Categories for INDOCYANINE GREEN
Anatomical Therapeutic Chemical (ATC) Classes for INDOCYANINE GREEN

US Patents and Regulatory Information for INDOCYANINE GREEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Renew Pharms INDOCYANINE GREEN indocyanine green INJECTABLE;INJECTION 040811-001 Nov 21, 2007 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.